VERTEX PHARMACEUTICALS INC / MA (VRTX) Net margin 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) net profit margin by fiscal year — reported net income divided by reported revenue.
32.9%FY2025 · since FY2016: -6.6% → 32.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 32.9% | +37.8 pp |
| FY2024 | -4.9% | -41.5 pp |
| FY2023 | 36.7% | -0.5 pp |
| FY2022 | 37.2% | +6.3 pp |
| FY2021 | 30.9% | -12.8 pp |
| FY2020 | 43.7% | +15.4 pp |
| FY2019 | 28.3% | -40.5 pp |
| FY2018 | 68.8% | +58.2 pp |
| FY2017 | 10.6% | +17.2 pp |
| FY2016 | -6.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice